Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PTPRC | P08575 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL440760 | 0.90 | CDC25B (0.38) | IDO1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL26205058 | 0.84 | NQO1 (0.31) | — | |
| SCHEMBL3444764 | 0.83 | MEN1 (0.48) | IDO1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL126239 | 0.75 | CDC25B (0.33) | IDO1CDC25BMAOAMAOBAKT1 | |
| SCHEMBL5207877 | 0.75 | CDC25B (0.36) | IDO1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL8936319 | 0.75 | GPR84 (0.33) | CES1 | |
| SCHEMBL11039168 | 0.71 | — | — | |
| SCHEMBL11039148 | 0.71 | — | — | |
| SCHEMBL4076256 | 0.71 | IDO1 (0.35) | IDO1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL29534849 | 0.70 | PTPRC (0.46) | IDO1MEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230213863-A1 | COMPOUND, RESIST UNDERLAYER FILM COMPOSITION INCLUDING SAME, AND RESIST UNDERLAYER FILM | DONGJIN SEMICHEM CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230213863-A1 | COMPOUND, RESIST UNDERLAYER FILM COMPOSITION INCLUDING SAME, AND RESIST UNDERLAYER FILM | DONGJIN SEMICHEM CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-8895725-B2 | Use of 9, 10-anthraquinone compounds | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) | 2014-11-25 | — | — | US | disclosed |
| US-20110224414-A1 | USE OF 9, 10-ANTHRAQUINONE COMPOUNDS | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224414-A1 | USE OF 9, 10-ANTHRAQUINONE COMPOUNDS | HCCS, CYC1, C1S | IDO1 1885/4885MEN1 4181/4885KMT2A 3695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.